Table 4.
C57BL/6 | CBA/Ca | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Group | Day | LD | Dose (Gy) |
Lower 95% CI |
Upper 95% CI |
Group | Day | LD | Dose (Gy) |
Lower 95% CI |
Upper 95% CI |
PBI BM40 +
Cipro (240) |
6 | 30 | 15.4 | 15.0 | 15.8 |
PBI BM40 +
Cipro (180) |
6 | 30 | 15.6 | 15.0 | 16.3 |
PBI BM40 +
Cipro (240) |
6 | 50 | 16.1 | 15.6 | 16.6 |
PBI BM40 +
Cipro (180) |
6 | 50 | 16.5 | 15.5 | 17.5 |
PBI BM40 +
Cipro (240) |
6 | 70 | 16.7 | 16.0 | 17.5 |
PBI BM40 +
Cipro (180) |
6 | 70 | 17.3 | 15.9 | 18.9 |
PBI BM40 +
Cipro (240) |
7 | 30 | 15.2 | 14.8 | 15.6 |
PBI BM40 +
Cipro (180) |
7 | 30 | 15.0 | 14.5 | 15.4 |
PBI BM40 +
Cipro (240) |
7 | 50 | 15.8 | 15.3 | 16.3 |
PBI BM40 +
Cipro (180) |
7 | 50 | 15.7 | 15.1 | 16.2 |
PBI BM40 +
Cipro (240) |
7 | 70 | 16.5 | 15.8 | 17.1 |
PBI BM40 +
Cipro (180) |
7 | 70 | 16.4 | 15.6 | 17.2 |
PBI BM40 +
Cipro (240) |
8 | 30 | 14.6 | 14.3 | 15.0 |
PBI BM40 +
Cipro (180) |
8 | 30 | 14.9 | 14.5 | 15.4 |
PBI BM40 +
Cipro (240) |
8 | 50 | 15.2 | 14.9 | 15.6 |
PBI BM40 +
Cipro (180) |
8 | 50 | 15.6 | 15.1 | 16.1 |
PBI BM40 +
Cipro (240) |
8 | 70 | 15.9 | 15.4 | 16.4 |
PBI BM40 +
Cipro (180) |
8 | 70 | 16.2 | 15.5 | 17.0 |
PBI BM40 +
Cipro (240) |
20 | 30 | 14.2 | 13.9 | 14.6 |
PBI BM40 +
Cipro (180) |
20 | 30 | 14.9 | 14.5 | 15.4 |
PBI BM40 +
Cipro (240) |
20 | 50 | 14.8 | 14.5 | 15.2 |
PBI BM40 +
Cipro (180) |
20 | 50 | 15.6 | 15.1 | 16.1 |
PBI BM40 +
Cipro (240) |
20 | 70 | 15.5 | 15.0 | 15.9 |
PBI BM40 +
Cipro (180) |
20 | 70 | 16.2 | 15.5 | 17.0 |